State-of-the-art gene therapy for inherited retinal disorders

<p> O.I. Orenburkina<sup>1</sup>, A.E. Babushkin<sup>2</sup> </p> <p> <sup>1</sup>Russian Center for Eye and Plastic Surgery of the Bashkir State Medical University, Ufa, Russian Federation </p> <p> <sup>2</sup>Ufa Res...

Full description

Saved in:
Bibliographic Details
Main Authors: O.I. Orenburkina, A.E. Babushkin
Format: Article
Language:Russian
Published: Prime-Media 2024-03-01
Series:РМЖ "Клиническая офтальмология"
Online Access:http://clinopht.com/upload/iblock/ff1/7v40uqpui2zoshlwgh1do67te87v5ye3.ru
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526904078729216
author O.I. Orenburkina
A.E. Babushkin
author_facet O.I. Orenburkina
A.E. Babushkin
author_sort O.I. Orenburkina
collection DOAJ
description <p> O.I. Orenburkina<sup>1</sup>, A.E. Babushkin<sup>2</sup> </p> <p> <sup>1</sup>Russian Center for Eye and Plastic Surgery of the Bashkir State Medical University, Ufa, Russian Federation </p> <p> <sup>2</sup>Ufa Research Institute of Eye Diseases of the Bashkir State Medical University, Ufa, Russian Federation </p> <p> Inherited retinal diseases (IRDs), which are orphan diseases, are a relevant social issue due to severe visual impairment and disability in children and working-age individuals. More than 100 IRDs caused by various defects in about 270 genes are known. Molecular genetic diagnostics is essential for identifying a specific hereditary factor of the disease. One of them is the RPE65 protein that is most highly expressed in the retinal pigment epithelium. Gene replacement therapy (GRT) with single subretinal administration of voretigene neparvovec has already been developed for hereditary retinal dystrophies caused by established biallelic mutations in the RPE65 gene, i.e., Leber congenital amaurosis 2 and retinitis pigmentosa 20. Studies (including domestic ones) have demonstrated a positive effect of this drug, particularly in children. The results of GRT for other neurological disorders have been obtained mostly in experimental studies. However, there are reasons to speak about the prospects of its future implementation in clinical practice. </p> <p> <b>Keywords</b>: inherited retinal diseases, hereditary retinal dystrophies, retinitis pigmentosa, Leber congenital amaurosis, gene replacement therapy, voretigene neparvovec. </p> <p> <b>For citation:</b> Orenburkina O.I., Babushkin A.E. State-of-the-art gene therapy for inherited retinal disorders. Russian Journal of Clinical Ophthalmology. 2024;24(1):41–45 (in Russ.). DOI: 10.32364/2311-7729-2024-24-1-8. </p>
format Article
id doaj-art-aea95117c8994bd69db36b8313506e72
institution Kabale University
issn 2311-7729
2619-1571
language Russian
publishDate 2024-03-01
publisher Prime-Media
record_format Article
series РМЖ "Клиническая офтальмология"
spelling doaj-art-aea95117c8994bd69db36b8313506e722025-01-16T09:39:37ZrusPrime-MediaРМЖ "Клиническая офтальмология"2311-77292619-15712024-03-0124131703State-of-the-art gene therapy for inherited retinal disordersO.I. Orenburkina0A.E. Babushkin1Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<p> O.I. Orenburkina<sup>1</sup>, A.E. Babushkin<sup>2</sup> </p> <p> <sup>1</sup>Russian Center for Eye and Plastic Surgery of the Bashkir State Medical University, Ufa, Russian Federation </p> <p> <sup>2</sup>Ufa Research Institute of Eye Diseases of the Bashkir State Medical University, Ufa, Russian Federation </p> <p> Inherited retinal diseases (IRDs), which are orphan diseases, are a relevant social issue due to severe visual impairment and disability in children and working-age individuals. More than 100 IRDs caused by various defects in about 270 genes are known. Molecular genetic diagnostics is essential for identifying a specific hereditary factor of the disease. One of them is the RPE65 protein that is most highly expressed in the retinal pigment epithelium. Gene replacement therapy (GRT) with single subretinal administration of voretigene neparvovec has already been developed for hereditary retinal dystrophies caused by established biallelic mutations in the RPE65 gene, i.e., Leber congenital amaurosis 2 and retinitis pigmentosa 20. Studies (including domestic ones) have demonstrated a positive effect of this drug, particularly in children. The results of GRT for other neurological disorders have been obtained mostly in experimental studies. However, there are reasons to speak about the prospects of its future implementation in clinical practice. </p> <p> <b>Keywords</b>: inherited retinal diseases, hereditary retinal dystrophies, retinitis pigmentosa, Leber congenital amaurosis, gene replacement therapy, voretigene neparvovec. </p> <p> <b>For citation:</b> Orenburkina O.I., Babushkin A.E. State-of-the-art gene therapy for inherited retinal disorders. Russian Journal of Clinical Ophthalmology. 2024;24(1):41–45 (in Russ.). DOI: 10.32364/2311-7729-2024-24-1-8. </p>http://clinopht.com/upload/iblock/ff1/7v40uqpui2zoshlwgh1do67te87v5ye3.ru
spellingShingle O.I. Orenburkina
A.E. Babushkin
State-of-the-art gene therapy for inherited retinal disorders
РМЖ "Клиническая офтальмология"
title State-of-the-art gene therapy for inherited retinal disorders
title_full State-of-the-art gene therapy for inherited retinal disorders
title_fullStr State-of-the-art gene therapy for inherited retinal disorders
title_full_unstemmed State-of-the-art gene therapy for inherited retinal disorders
title_short State-of-the-art gene therapy for inherited retinal disorders
title_sort state of the art gene therapy for inherited retinal disorders
url http://clinopht.com/upload/iblock/ff1/7v40uqpui2zoshlwgh1do67te87v5ye3.ru
work_keys_str_mv AT oiorenburkina stateoftheartgenetherapyforinheritedretinaldisorders
AT aebabushkin stateoftheartgenetherapyforinheritedretinaldisorders